SYNTHESIS OF ∆2-ISOXAZOLINE FATTY ACID ESTERS
1047
NMR: δ 174.3 (C=O), 158.9 (C=N), 80.0 (CH2–HC(O)–CH2),
Representative procedure for the synthesis of ∆2-isoxazo-
51.4 (O–CH3), 42.1, 35.2, 34.7, 31.7, 29.4, 29.3, 29.1, 28.9, lines from methyl 10-undecenoate and syn-benzaldehyde
27.8, 26.4, 25.5, 24.9, 22.6, 14.0 (–CH3). IR (NaCl) cm−1: oxime using N-chlorosuccinimide (9). To a stirred mixture of
2930, 2857, 1740 (C=O), 1622 (C=N). 5-(9-Methyl N-chlorosuccinimide (NCS; 1.10 g, 8.1 mmol), pyridine (38
nonanoate)-3-pentyl-∆2-isoxazoline GC retention time 15.1 µL, 0.47 mmol), in dry chloroform (7.5 mL) at 24°C was
min. MS (EI): m/z 311 (M+, 2%), 280 (M+ − CH3O, 2%) and added syn-benzaldehyde oxime (1.0 g, 8.2 mmol) in one por-
140 (C8H14NO+, 100%). MS (CI): m/z 312 (MH+, 100%), 340 tion. The mixture was allowed to stir ca. 20 min, after which
(M+ + C2H5, 17%), 352 (M+ + C3H5, 6%), 280 (M+ − CH3O, time the suspended NCS had disappeared. Methyl 10-unde-
11%), and 140 (C8H14NO+, 3%).
cenoate (2.0 g, 10.1 mmol) was added, and the temperature
The 5-(9-methyl nonanoate)-3-hexyl-∆2-isoxazoline (4c) raised to 50°C. Triethylamine (1.17 mL, 8.4 mmol) in CHCl3
purified by column chromatography: 1H NMR δ 4.55–4.45 (2 mL) was added dropwise over 30–35 min, and the reaction
(m, 1H, CH2–HC(O)–CH2), 3.68 (s, 3H, OCH3), 2.96 (dd, solution was then stirred at 50°C for 4.5 h. The reaction solu-
1H, J = 16.7 and 10.1 Hz, –(O)CH–CH2–C(=N)–), 2.54 (dd, tion was cooled, washed with water (2 × 10 mL), dried
1H, J = 16.7 and 8.1 Hz, –(O)CH–CH2–C(=N)–), 2.36–2.28 (MgSO4), and evaporated in vacuo to obtain 3.0 g of a crude
(m, 4H, CH2–CH2–COOMe and –C(=N)–CH2–CH2–), oil. One recrystallization from methanol gave 1.04 g of 4e as
1.70–1.20 (m, 22H, alkyl chain H), 0.90 (t, 3H, J = 6.9 Hz, white crystals (41%), m.p.: 59–60°C.
–CH2–CH3). 13C NMR: δ 174.3 (C=O), 158.9 (C=N), 80.0
Representative procedure for the synthesis of 5-(9-methyl
(CH2–HC(O)–CH2), 51.4 (O–CH3), 42.1, 35.2, 34.1, 31.5, nonanoate)-3-carbalkoxy-∆2-isoxazoline 4g and 4h from
29.4, 29.3, 29.1, 29.1, 28.9, 27.8, 26.4, 25.5, 24.9, 22.5, 14.0 methyl 10-undecenoate and alkylchlorooximidoacetate. To a
(–CH3). IR (NaCl) cm−1: 2930, 2857, 1740 (C=O), 1622 vigorously stirred solution of methyl 10-undecenoate (1.08 g,
(C=N). 5-(9-Methyl nonanoate)-3-hexyl-∆2-isoxazoline GC 5.5 mmol) and ethyl chlorooximidoacetate (763 mg, 5.1
retention time 16.6 min. MS (EI): m/z 325 (M+, 2%), 294 mmol) in ethyl ether (14 mL) was added a solution of triethyl-
(M+ − CH3O, 0.3%), and 154 (C9H16NO+, 100%). MS (CI): amine (700 µL, 5.02 mmol) in ethyl ether (10 mL) dropwise
m/z 326 (MH+, 100%), 354 (M+ + C2H5, 17%), 366 (M+ + at room temperature over 1 h. A white precipitate formed
C3H5, 6%), 294 (M+ − CH3O, 8%), and 154 (C9H16NO+, 3%). upon triethylamine addition. After stirring an additional 2 h,
The 5-(9-methyl nonanoate)-3-heptyl-∆2-isoxazoline (4d) the reaction mixture was taken up in water (10 mL) and ex-
purified by column chromatography: 1H NMR δ 4.51–4.43 (m, tracted with ethyl ether (3 × 30 mL). The combined ether ex-
1H, CH2–HC(O)–CH2), 3.64 (s, 3H, OCH3), 2.92 (dd, 1H, J = tracts were washed with water (10 mL), dried (MgSO4), and
16.7 and 10.1 Hz, –(O)CH–CH2–C(=N)–), 2.50 (dd, 1H, J = concentrated. The crude product was chromatographed on sil-
16.8 and 8.1 Hz, –(O)CH–CH2–C(=N)–), 2.32–2.25 (m, 4H, ica gel as described for the previous isoxazolines. Product 4g
CH2–CH2–COOMe and –C(=N)–CH2–CH2–), 1.75–1.15 (m, (1.1 g, 66%) was obtained as a clear oil.
24H, alkyl chain H), 0.85 (t, 3H, J = 6.9 Hz, –CH2–CH3). 13
C
1H NMR of 5-(9-methyl nonanoate)-3-carbethoxy-∆2-isox-
NMR: δ 174.3 (C=O), 158.9 (C=N), 80.0 (CH2–HC(O)–CH2), azoline (4g): δ 4.70–4.80 (m, 1H, CH2–HC(O)–CH2), 4.30 (q,
51.4 (O–CH3), 42.0, 35.2, 34.1, 31.7, 29.4, 29.3, 29.2, 29.1, 2H, J = 10.71 and 7.1 Hz, –OCH2CH3), 3.62 (s, 3H, OCH3),
29.1, 28.9, 27.8, 26.4, 25.5, 24.9, 22.6, 14.0 (–CH3). IR (KBr) 3.21 (dd, 1H, J = 17.5 and 10.9 Hz, –(O)CH–CH2–C(=N)–),
cm−1: 2926, 2852, 1738 (C=O), 1632 (C=N). 5-(9-Methyl 2.79 (dd, 1H, J = 17.5 and 8.5 Hz, –(O)CH–CH2–C(=N)–), 2.26
nonanoate)-3-heptyl-∆2-isoxazoline GC retention time 18.5 (t, 2H, J = 7.5 Hz, CH2–CH2–COOMe), 1.80–1.10 (m, 17H,
min. MS (EI): m/z 339 (M+, 2%), 308 (M+ − CH3O, 1%) and alkyl chain H and –O–CH2–CH3). 13C NMR: δ 174.1 (C=O,
168 (C10H18NO+, 100%). MS (CI): m/z 340 (MH+, 100%), methyl ester), 160.8 (C=O, ethyl ester), 151.2 (C=N), 84.0
368 (M+ + C2H5, 16%), 380 (M+ + C3H5, 5%), 308 (M+ − (CH2–HC(O)–CH2), 61.9 (–O–CH2CH3), 51.3 (O–CH3), 38.2,
CH3O, 8%), and 168 (C10H18NO+, 4%).
34.9, 33.9, 29.1, 29.1, 28.9, 28.9, 24.9, 24.7, 14.0 (–CH3). IR
The 5-(9-methyl nonanoate)-3-t-butyl-∆2-isoxazoline (4f) (NaCl) cm−1: 2932, 2857, 1739 (C=O), 1721 (C=O), 1587
purified by column chromatography: 1H NMR δ 4.51–4.43 (C=N). 5-(9-Methyl nonanoate)-3-carbethoxy-∆2-isoxazoline
(m, 1H, CH2–HC(O)–CH2), 3.64 (s, 3H, OCH3), 2.97 (dd, GC retention time 14.53 min. MS (EI): m/z 314 (MH+, 2%), 282
1H, J = 16.5 and 10.0 Hz, –(O)CH–CH2–C(=N)–), 2.54 (dd, (M+ − CH3O, 4%), 240 (M+ − C2H5O2, 7%), and 142
1H, J = 16.6 and 8.0 Hz, –(O)CH–CH2–C(=N)–), 2.28 (t, 2H, (C6H8NO3 , 100%). MS (CI): m/z 314 (MH+, 66%), 342 (M+ +
+
J = 7.5 Hz, CH2–CH2–COOMe), 1.75–1.2 (m, 14H, alkyl C2H5, 25%), 354 (M+ + C3H5, 7%), 282 (M+ − CH3O, 100%).
chain H), 1.17 (s, 9H, –C(CH3)3). 13C NMR: δ 174.4 (C=O),
The 5-(9-methyl nonanoate)-3-carbmethoxy-∆2-isoxazo-
1
165.9 (C=N), 80.4 (CH2–HC(O)–CH2), 51.5 (O–CH3), 39.4, line (4h) purified by column chromatography: H NMR
35.2, 34.1, 33.0, 29.4, 29.4, 29.2, 29.1, 28.1, 25.6, 25.0. 5-(9- δ 4.72–4.85 (m, 1H, CH2–HC(O)–CH2), 3.87 (s, 3H, OCH3),
Methyl nonanoate)-3-t-butyl-∆2-isoxazoline GC retention 3.65 (s, 3H, OCH3), 3.23 (dd, 1H, J = 17.5 and 10.9
time 12.7 min. IR (NaCl) cm−1: 2931, 2857, 1740 (C=O), Hz, –(O)CH–CH2–C(=N)–), 2.82 (dd, 1H, J = 17.5 and 8.5
1609 (C=N). MS (EI): m/z 297 (M+, 2%), 240 (M+ − C4H9, Hz, –(O)CH–CH2–C(=N)–), 2.29 (t, 2H, J = 7.5 Hz,
1%), and 126 (C7H12NO+, 100%). MS (CI): m/z 298 (MH+, CH2–CH2–COOMe), 1.90–1.10 (m, 14H, alkyl chain H). 13
C
100%), 326 (M + C2H5, 12%), 338 (M + C3H5, 3%), and 126 NMR: δ 174.2 (C=O, methyl ester), 161.2 (C=O, methyl
(C7H12NO+, 2%).
ester), 151.1 (C=N), 84.2 (CH2–HC(O)–CH2), 52.7 (O–CH3),
JAOCS, Vol. 78, no. 10 (2001)